2026 NPPES data Podiatrist NPI 1427003284 MD
Verify on CMS →

RORY PANEPINTO, MD

Podiatrist in METAIRIE, Louisiana. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
916
Medicare Part D claims · 421 beneficiaries · Podiatrist avg: 304
Generic prescribing
96%
generic claims · 4% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
0/100
▼ 83 pts below national avg 83.1 · [object Object]
Industry payments
$1.5K
27 payments · CMS Open Payments (Sunshine Act)
What the federal data reveals: RORY PANEPINTO, MD is a Podiatrist ([object Object]) practicing in METAIRIE, Louisiana with a Medicare Part D prescribing footprint of 916 claims across 421 beneficiaries — 4% brand-name prescribing . Their CMS MIPS Final Score of 0/100 (national average: 83.1) reflects performance across Quality, Cost, Interoperability, and Improvement Activities . Industry payments of $1.5K across 27 transactions are disclosed under CMS Open Payments (Sunshine Act).

What stands out: RORY PANEPINTO, MD reported a CMS MIPS final score of 0 out of 100, below the 83.1 national average, and filed 916 Medicare Part D claims in 2023. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.

RORY PANEPINTO, MD at a glance

Below national average

NPI registry status

Active

Issued 05/23/2006

NPI 1427003284

Primary specialty

Podiatrist

Mid-sized

10,498 US NPIs in this specialty

Medicare Part D claims

916 201% vs specialty avg

2023 prescription claims

Specialty avg: 304

MIPS final score

0/100 83.1% pts

Penalty band band

vs 83.1 national avg

Specialty distribution in Louisiana

How Podiatrist compares to other specialties among Louisiana providers

Louisiana providers

Podiatrist share within Louisiana

1. Podiatrist42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Podiatrist share within Louisiana

Medicare quality performance — MIPS

RORY PANEPINTO, MD's 2023 MIPS final score plotted against the Podiatrist national average

Below national average
MIPS Final Score
0/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Podiatrist) — 0/100 vs national avg 83.1

0%100%National avg83%0%
MIPS final score (Podiatrist) — 0/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

RORY PANEPINTO, MD is a Podiatrist provider practicing in METAIRIE, Louisiana, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: MD. NPI: 1427003284. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

RORY PANEPINTO, MD appears in the CMS NPPES registry as a Podiatrist provider holding MD credentials at 1801 CLEARVIEW PARKWAY, METAIRIE, LA, 70001, with a listed phone of (504) 264-3668. NPI 1427003284 was issued on 05/23/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what PANEPINTO most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 916 prescription claims written by this provider, covering 421 Medicare beneficiaries and totaling roughly $85K in drug spend, split 4% brand-name and 96% generic by claim count, with an opioid prescribing rate of 6.1%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 0/100 for the 2023 performance year (Quality 0), compared with the national average of 83.1.

Podiatrist is a mid-sized specialty nationwide, with 10,498 enrolled providers across 54 states and an average of 304 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

1801 CLEARVIEW PARKWAY
METAIRIE, LA 70001

Provider Details

NPI 1427003284
Specialty Podiatrist
Credentials MD
Gender Male
NPI Issued 05/23/2006

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

0
Final Score
Avg: 83.1
0
Quality

Reporting: Individual

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for RORY PANEPINTO, MD. Source: openpaymentsdata.cms.gov.

Total received

$1.5K

Largest payer

International Life Sciences

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

Brand vs generic prescribing mix · Generic-heavy

RORY PANEPINTO, MD — brand share 4.0%
Specialty average (est.)

4% brand-name claims vs 96% generic, on 916 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

916
Total Claims
$85K
Total Drug Cost
421
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
983
Total Day Supply
20,589
Brand vs Generic
4% brand / 96% generic
Brand Drug Cost
$46K
Generic Drug Cost
$39K
Opioid Claims
56 (6.1% rate)
Antibiotic Claims
288

Patient Demographics

Average Patient Age
72.3 years
Avg HCC Risk Score
1.43
Gender Split
67% female / 33% male
Age Distribution
<65: 44, 65-74: 217, 75-84: 130, 85+: 30

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Ketoconazole
210
Amoxicillin
77
Terbinafine Hcl
77
Doxycycline Hyclate
73
Ibuprofen
56
Levofloxacin
42
Promethazine Hcl
42
Cephalexin
38
Oxycodone-Acetaminophen
Oxycodone Hcl/Acetaminophen
25
Clindamycin Hcl
24

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Podiatrist Overview

How RORY PANEPINTO, MD fits within the Podiatrist landscape nationally.

10,498
Podiatrist Providers in US
54
States with Podiatrist
304
Avg Claims per Provider

RORY PANEPINTO, MD's 916 claims are above the specialty average of 304.

Nearby Podiatrist Providers in Louisiana

Other clinicians with the same primary specialty enrolled in Louisiana, drawn from the same CMS NPPES roster as PANEPINTO.

Compare Podiatrist nationally: see state-by-state distribution →

Frequently Asked Questions

What is RORY PANEPINTO, MD's specialty?
RORY PANEPINTO, MD specializes in Podiatrist and practices in METAIRIE, Louisiana. Credentials: MD.
How much does RORY PANEPINTO, MD prescribe under Medicare Part D?
In 2023, RORY PANEPINTO, MD wrote 916 Medicare Part D claims totaling $85K in drug costs for 421 beneficiaries.
What is RORY PANEPINTO, MD's Medicare quality score?
RORY PANEPINTO, MD has a CMS MIPS Final Score of 0/100 (Quality: 0). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is RORY PANEPINTO, MD located?
RORY PANEPINTO, MD is located at 1801 CLEARVIEW PARKWAY, METAIRIE, LA, 70001. Phone: (504) 264-3668.
What is RORY PANEPINTO, MD's NPI number?
RORY PANEPINTO, MD's National Provider Identifier (NPI) is 1427003284, issued on 05/23/2006.
Does RORY PANEPINTO, MD prescribe more brand-name or generic drugs?
RORY PANEPINTO, MD's prescribing is 4% brand-name and 96% generic drugs by claim count, with $46K in brand drug costs.
Does RORY PANEPINTO, MD prescribe opioids?
Yes, RORY PANEPINTO, MD had 56 opioid claims in 2023 with an opioid prescribing rate of 6.1%.
How many Podiatrist providers are there in the US?
There are 10,498 Podiatrist providers across 54 states in the US. The average Podiatrist provider writes 304 Medicare Part D claims per year.
What drugs does RORY PANEPINTO, MD prescribe most often?
Based on 2023 Medicare Part D data, RORY PANEPINTO, MD's most frequently prescribed drugs include Ketoconazole, Amoxicillin, Terbinafine Hcl. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does RORY PANEPINTO, MD accept Medicare?
RORY PANEPINTO, MD appears in CMS Medicare data with 916 Part D claims and 421 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify RORY PANEPINTO, MD's credentials?
RORY PANEPINTO, MD's NPI is 1427003284 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology